Diagnosis of early Alzheimer's disease

Revue Neurologique

Volumn 155, Issue SUPPL. 4, 1999, Pages

  Fox, N C ^a,b   Rossor, M N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN MAPPING; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMAN; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033454730     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. BOWEN J, TERI L, KUKULL W, MCCORMICK W, MCCURRY SM, LARSON EB. (1997) . Progression to dementia in patients with isolated memory loss. Lancet, 349: 763-765.
2. CONVIT A, DE LEON MJ, TARSHISH C, DE SANTI S, KLUGER A, RUSINEK H, GEORGE AE. (1995). Hippocampal volume losses in minimally impaired elderly [letter]. Lancet, 345: 266-266.
3. DE LEON MJ, GOLOMB J, GEORGE AE, CONVIT A, TARSHISH CY, MCRAE T, DE SANTI S, SMITH G, FERRIS SH, NOZ M, RUSINEK H. (1993). The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR, 14: 897-906.
4. FABRIGOULE C, ROUCH I, TABERLY A, LETENNEUR L, COMMENGES D, MAZAUX JM, ORGOGOZO JM, DARTIGUES JF. (1998). Cognitive process in preclinical phase of dementia. Brain, 121: 135-141.
5. FOX NC, FREEBOROUGH PA, ROSSOR MN (1996) .Visualisation and quantification of atrophy in Alzheimer's disease. Lancet, 348: 94-97
6. FOX NC, WARRINGTON EK, SEIFFER AS, AGNEW SK, ROSSOR MN. (1998). Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain, 121: 1631-1639
7. GRADY CL, HAXBY JV, HORWITZ B, GILLETTE J, SALERNO JA, GONZALEZ AA, CARSON RE, HERSCOVITCH P, SCHAPIRO MB, RAPOPORT SI. (1993). Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol. Aging, 14: 35-44
8. HARDY J. (1997). Amyloid, the presenilins and Alzheimer's disease. Trends in Neurosciences, 20: 154-159.
9. JACK CR, PETERSEN RC, XU YC, WARING SC, O'BRIEN PC, TANGALOS EG, SMITH GE, IVNIK RJ, KOKMEN E. (1997). Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurol, 49: 786-794.
10. JOBST KA, SMITH AD, SZATMARI M, ESIRI MM, JASKOWSKI S, HINDLEY N, MCDONALD B, MOLYNEUX AJ. (1994). Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet, 343: 829-830.
11. JOBST KA, SMITH AD, SZATMARI M, MOLYNEUX A, ESIRI ME, KING E, SMITH A, JASKOWSKI A, MCDONALD B, WALD N. (1992). Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet, 340: 1179-1183
12. JOST BC, GROSSBERG GT. (1995). The natural history of Alzheimer's disease: a brain bank study [see comments]. J Am Geriatr Soc, 43: 1248-1255.
13. KELLY CA, HARVEY RJ, CAYTON H. (1997). Drug treatments for Alzheimer's disease [editorial]. BMJ, 314: 693-694.
14. KENNEDY AM, FRACKOWIAK RSJ, NEWMAN SK, BLOOMFIELD PM, SEAWARD J, ROQUES P, LEWINGTON G, CUNNINGHAM VJ, ROSSOR MN. (1995). Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett, 186: 17-20.
15. KESSLER J, GHAEMI M, MIELKE R, HERHOLZ K, HEISS WD. (1996). Visual versus auditory memory stimulation in patients with probable Alzheimer's disease. A PET study with 18 FDG. Ann NY Acad Sci, 777: 233-238.
16. LINN RT, WOLF PA, BACHMAN DL, KNOEFEL JE, COBB JL, BELANGER AJ, KAPLAN EF, D'AGOSTINO RB. (1995). The "preclinical phase" of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol, 52: 485-490.
17. LIPPA CF, HAMOS JE, PULASKI SALO D, DEGENNARO LJ, DRACHMAN DA. (1992). Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging, 13: 405-411.
18. NEWMAN SK, WARRINGTON EK, KENNEDY AM, ROSSOR MN. (1994). The earliest cognitive change in a person with familial Alzheimers-disease - presymptomatic neuropsychological features in a pedigree with familial Alzheimers-disease confirmed at necropsy. Journal of Neurology, Neurosurgery & Psychiatry, 57: 967-972.
19. REIMAN EM, CASELLI RJ, YUN LS, CHEN K, BANDY D, MINOSHIMA S, THIBODEAU SN, OSBORNE D. (1996). Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E [see comments]. N Engl J Med, 334: 752-758.
20. SMALL GW, MAZZIOTTA JC, COLLINS MT, BAXTER LR, PHELPS ME, MANDELKERN MA, KAPLAN A, LARUE A, ADAMSON CF, CHANG L, GUZE BH, CORDER EH, SAUNDERS AM, HAINES JL, PERICAKVANCE MA, ROSES AD. (1995). Apolipoprotein-e type-4 allele and cerebral glucose-metabolism in relatives at risk for familial Alzheimer-disease. JAMA, 273: 942-947.
21. TIERNEY MC, SZALAI JP, SNOW WG, FISHER RH, NORES A, NADON G, DUNN E, St. (1996). Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurol, 46: 661-665
22. VAN DUIJN CM, HOFMAN A. (1992). Risk factors for Alzheimer's disease: the EURODEM collaborative re-analysis of case-control studies. Neuroepidemiology, 11 Suppl 1: 106-113.